Vaxa serves different parts of the healthcare ecosystem, including:
- Pharmaceuticals & Biotechnology
- Healthcare service providers
- Medical Devices
- Insurance
Pharma and Biotech companies are facing mounting pressures to innovate and deliver blockbuster drugs. Some relief is gained from genomics that has the potential to provide a quantum lead forward in how drugs are discovered. However, some parts of R&D is not working as well as others like clinical trials.
Device makers are trying to increase productivity by focusing on solutions and not just products. Their goals is to assist healthcare providers to increase patient throughput while decrease overall cost of care.
The major problem for healthcare service providers is the rising demand for services due to longer life expectancy and increasing elderly population. Costs contnue to rise due to increasing services demand but with decreasing government support, & pressure from insurers.
Vaxa's Healthcare Value Proposition
Vaxa has created identified new major revenue opportunities for all participants in healthcare industry as well as for IT companies looking to solve the major scientific and business issues within healthcare.
Vaxa has helped identified opportuities as large as $40B/year, created wholly new product segments, delved deeply into major business and consumer healthcare trends, and assisted companies to create a range of go-to-market strategies & tactics.
To find our more about Vaxa's work in this area, please contact us at heathcare@vaxainc.com .
|
